Company Filing History:
Years Active: 2007
Title: Mathilde Varret: Innovator in Genetic Research
Introduction
Mathilde Varret is a prominent inventor based in Chatillon, France. She has made significant contributions to the field of genetic research, particularly in the area of hypercholesterolemia. Her work focuses on the identification of genetic factors that contribute to this condition, which has implications for diagnosis and treatment.
Latest Patents
Mathilde Varret holds a patent for "Methods for detecting the presence of or predisposition to autosomal dominant hypercholesterolemia." This invention discloses the identification of a human hypercholesterolemia causal gene, which can be utilized for the diagnosis, prevention, and treatment of hypercholesterolemia, especially familial hypercholesterolemia. The invention specifically reveals that mutations in the PCSK9 gene encoding NARC-1 cause autosomal dominant hypercholesterolemia and represent novel targets for therapeutic intervention. This invention can also be applied in the diagnosis of predisposition to, detection, prevention, and/or treatment of coronary heart disease and disorders related to cholesterol, lipid, and lipoprotein metabolism.
Career Highlights
Mathilde Varret is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she continues her research and innovation in genetic studies. Her work has garnered attention for its potential impact on public health and medical treatments.
Collaborations
She has collaborated with notable colleagues, including Marianne Abi Fadel and Catherine Boileau, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mathilde Varret's contributions to genetic research, particularly in the context of hypercholesterolemia, highlight her role as an influential inventor. Her patented methods pave the way for advancements in diagnosis and treatment, showcasing the importance of innovation in healthcare.